Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis-Addicted Breast Tumor Growth
S.L. Geeraerts, K.R. Kampen, G. Rinaldi, P. Gupta, M. Planque, N. Louros, E. Heylen, K. De Cremer, K. De Brucker, S. Vereecke, B. Verbelen, P. Vermeersch, J. Schymkowitz, F. Rousseau, D. Cassiman, S.M. Fendt, A. Voet, B.P.A. Cammue, K. Thevissen*, K. De Keersmaecker*
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis-Addicted Breast Tumor Growth'. Together they form a unique fingerprint.